Complement Proteins May Serve as Potential Biomarkers and Therapeutic Targets in Sepsis
A systematic review and meta-analysis published in Critical Care evaluated differences in humoral immunity proteins between survivors and non-survivors in adult patients with sepsis. Thirty-six studies, including 6330 patients, were analyzed. Survivors had significantly higher levels of complement proteins C3 (SMD = 0.53; 95% CI, 0.07-0.99) and C4 (SMD = 0.51; 95% CI, 0.09-0.94) compared with non-survivors. Conversely, C4a (SMD = −1.17; 95% CI, −1.77 to −0.56]) and IgA (SMD = −0.21; 95% CI, −0.39 to −0.03) were significantly lower in survivors. No differences were found for IgG (SMD = 0.00; 95% CI, −0.18to 0.18), IgM (SMD = −0.02; 95% CI, −0.13 to 0.08), C5, C5a, or HBP. Proteomic data revealed early depletion of classical complement components (C3, C4B) and regulatory proteins in non-survivors. Sepsis non-survivors exhibit lower C3 and C4 and higher C4a, consistent with complement activation and/or depletion.